In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 11, 1996, Pages 2669-2670

  Kuo, Cho Chou ^a   Jackson, Lisa A ^a   Lee, Amy ^a   Grayston, J Thomas ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

14 HYDROXYCLARITHROMYCIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN LACTOBIONATE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TEMAFLOXACIN; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; ASTHMA; ATHEROSCLEROSIS; BACTERIUM ISOLATION; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SARCOIDOSIS;

EID: 0029910169     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.11.2669     Document Type: Article

References (18)

1. Campbell, J. F., R. C. Barnes, P. E. Kozarsky, and J. S. Spika. 1991. Culture-confirmed pneumonia due to Chlamydia pneumoniae. J. Infect. Dis. 164:411-413.
2. Chirgwin, K., P. M. Roblin, M. Gelling, M. R. Hammerschlag, and J. Schachter. 1991. Infection with Chlamydia pneumoniae in Brooklyn. J. Infect. Dis. 163:757-761.
3. Cooper, M. A., D. Baldwin, R. S. Matthews, J. M. Andrews, and R. Wise. 1991. In-vitro susceptibility of Chlamydia pneumoniae (TWAR) to seven antibiotics. J. Antimicrob. Chemother. 28:407-413.
4. Ekman, M.-R., J. T. Grayston, R. Visakorpi, M. Kleemola, C.-C. Kuo, and P. Saikku. 1993. An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin. Infect. Dis. 17:420-425.
5. Fernandes, P. B., R. Bailer, R. Swanson, C. W. Hanson, E. McDonald, N. Ramer, D. Hardy, N. Shipkowitz, R. R. Bower, and E. Gade. 1986. In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. Antimicrob. Agents Chemother. 30:865-873.
6. Goldstein, F. W., M. F. Emirian, A. Coutrot, and J. F. Acar. 1990. Bacteriostatic and bactericidal activity of azithromycin against Haemophilus influenzae. J. Antimicrob. Chemother. 25(Suppl. A):25-28.
7. Grayston, J. T., C.-C. Kuo, S.-P. Wang, and J. Altman. 1986. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infection. N. Engl. J. Med. 315:161-168.
8. Hammerschlag, M. R., C. L. Hyman, and P. M. Roblin. 1992. In vitro activities of five quinolones against Chlamydia pneumoniae. Antimicrob. Agents Chemother. 36:682-683.
9. Hammerschlag, M. R., K. K. Qumei, and P. M. Roblin. 1992. In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae. Antimicrob. Agents Chemother. 36:1573-1574.
10. Kimura, M., T. Kishimoto, Y. Niki, and R. Soejima. 1993. In vitro and in vivo antichlamydia activities of newly developed quinolone antimicrobial agents. Antimicrob. Agents Chemother. 37:801-803.
11. Kuo, C.-C., and J. T. Grayston. 1988. In vitro drug susceptibility of Chlamydia sp. strain TWAR. Antimicrob. Agents Chemother. 32:257-258.
12. Kuo, C.-C., and J. T. Grayston. 1991. In vitro susceptibility of Chlamydia pneumoniae, strain TWAR to clarithromycin. In Proceedings of the 17th International Congress of Chemotherapy.
13. Kuo, C.-C., L. A. Jackson, L. A. Campbell, and J. T. Grayston. 1995. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8:451-461.
14. Lipsky, B. A., K. J. Tack, S.-P. Wang, C.-C. Kuo, and J. T. Grayston. 1990. Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections. Am. J. Med. 89:722-724.
15. Nakata, K., Y. Okazaki, H. Hattori, and S. Nakamura. 1994. Protective effects of sparfloxacin in experimental pneumonia caused by Chlamydia pneumoniae in leutopenic mice. Antimicrob. Agents Chemother. 38:1757-1762.
16. Niki, Y., M. Kimura, N. Miyashita, and R. Soejima. 1994. In vitro and in vivo activities of azithromycin, a new azalide antibiotic, against chlamydia. Antimicrob. Agents Chemother. 38:2296-2299.
17. Retsema, J., A. Girard, W. Schelkly, M. Manousos, M. Anderson, G. Bright, R. Borovoy, L. Brennan, and R. Mason. 1987. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob. Agents Chemother. 31:1939-1947.
18. Yamazaki, T., H. Nakada, N. Sakurai, C.-C. Kuo, S.-P. Wang, and J. T. Grayston. 1990. Transmission of Chlamydia pneumoniae in young children in a Japanese family. J. Infect. Dis. 162:1390-1392.